XOMA Royalty (XOMA) Exchange Rate Effect (2011 - 2018)
XOMA Royalty (XOMA) reported Exchange Rate Effect of $20000.0 for Q1 2018, up 160.61% on a YoY basis from $7674.4 in Q1 2017, and up 66.67% sequentially from $12000.0 in Q4 2017.
XOMA Royalty (XOMA) Exchange Rate Effect (2011 - 2018) Analysis & Trends
XOMA Royalty (XOMA) has 6 years of Exchange Rate Effect data on file, last reported at $20000.0 in Q1 2018.
- For the quarter ending Q1 2018, Exchange Rate Effect rose 160.61% year-over-year to $20000.0; the trailing twelve-month figure through Dec 2018 stood at $20000.0 (down 88.83% YoY), and the FY2018 full-year result was $20000.0, down 88.83% from the prior year.
- Exchange Rate Effect advanced to $20000.0 in Q1 2018, from $12000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $194000.0 in Q3 2017 to a low of -$152000.0 in Q3 2014.
- A 5-year average of -$785.71 and a median of -$4000.0 in 2015 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 400.0% in 2017, while the deepest fall reached 1750.0% in 2017.
- Tracing XOMA's Exchange Rate Effect over 5 years: stood at -$15000.0 in 2014, then tumbled by 60.0% to -$24000.0 in 2015, then surged by 83.33% to -$4000.0 in 2016, then soared by 400.0% to $12000.0 in 2017, then soared by 66.67% to $20000.0 in 2018.
- Business Quant data shows XOMA's Exchange Rate Effect at $20000.0 in Q1 2018, $12000.0 in Q4 2017, and $194000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 20,000.00 |
| Mar 31, 2018 | 20,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Sep 30, 2017 | 194,000.00 |
| Sep 30, 2017 | 194,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Dec 31, 2016 | -4,000.00 |
| Dec 31, 2016 | -4,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | -24,000.00 |
| Dec 31, 2015 | -24,000.00 |
| Sep 30, 2015 | 14,000.00 |
| Sep 30, 2015 | 14,000.00 |